Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS WOCKHARDT IPCA LABS/
WOCKHARDT
 
P/E (TTM) x 52.0 -15.8 - View Chart
P/BV x 5.4 2.5 214.6% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 IPCA LABS   WOCKHARDT
EQUITY SHARE DATA
    IPCA LABS
Mar-23
WOCKHARDT
Mar-23
IPCA LABS/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs1,062316 336.6%   
Low Rs768145 528.4%   
Sales per share (Unadj.) Rs243.0184.0 132.1%  
Earnings per share (Unadj.) Rs19.4-43.1 -45.0%  
Cash flow per share (Unadj.) Rs29.7-25.7 -115.7%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs230.3231.7 99.4%  
Shares outstanding (eoy) m253.70144.09 176.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.3 300.7%   
Avg P/E ratio x47.2-5.3 -882.6%  
P/CF ratio (eoy) x30.8-9.0 -343.3%  
Price / Book Value ratio x4.01.0 399.5%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m232,12033,202 699.1%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8766,370 202.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64226,510 232.5%  
Other income Rs m1,5181,220 124.4%   
Total revenues Rs m63,16027,730 227.8%   
Gross profit Rs m9,033-1,930 -468.0%  
Depreciation Rs m2,6162,510 104.2%   
Interest Rs m4823,020 16.0%   
Profit before tax Rs m7,453-6,240 -119.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534-30 -8,445.3%   
Profit after tax Rs m4,919-6,210 -79.2%  
Gross profit margin %14.7-7.3 -201.3%  
Effective tax rate %34.00.5 7,070.9%   
Net profit margin %8.0-23.4 -34.1%  
BALANCE SHEET DATA
Current assets Rs m51,89319,140 271.1%   
Current liabilities Rs m18,05834,350 52.6%   
Net working cap to sales %54.9-57.4 -95.7%  
Current ratio x2.90.6 515.7%  
Inventory Days Days5139 130.1%  
Debtors Days Days611 53.4%  
Net fixed assets Rs m34,33648,670 70.5%   
Share capital Rs m254720 35.2%   
"Free" reserves Rs m58,16732,660 178.1%   
Net worth Rs m58,42033,380 175.0%   
Long term debt Rs m6,5182,240 291.0%   
Total assets Rs m86,22970,750 121.9%  
Interest coverage x16.5-1.1 -1,544.3%   
Debt to equity ratio x0.10.1 166.3%  
Sales to assets ratio x0.70.4 190.8%   
Return on assets %6.3-4.5 -138.9%  
Return on equity %8.4-18.6 -45.3%  
Return on capital %12.2-9.0 -135.2%  
Exports to sales %42.90-   
Imports to sales %13.33.5 382.3%   
Exports (fob) Rs m26,434NA-   
Imports (cif) Rs m8,178920 888.9%   
Fx inflow Rs m26,434730 3,621.1%   
Fx outflow Rs m8,178920 888.9%   
Net fx Rs m18,257-190 -9,608.8%   
CASH FLOW
From Operations Rs m8,0581,530 526.7%  
From Investments Rs m-7,250-1,250 580.0%  
From Financial Activity Rs m5,072-3,150 -161.0%  
Net Cashflow Rs m5,881-2,800 -210.0%  

Share Holding

Indian Promoters % 46.3 54.9 84.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 4.5 999.8%  
FIIs % 10.3 4.2 246.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 45.1 119.2%  
Shareholders   82,809 161,813 51.2%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Wockhardt Share Price Performance

Period IPCA Labs Wockhardt S&P BSE HEALTHCARE
1-Day 3.91% 4.99% 1.34%
1-Month 4.84% 0.15% -0.59%
1-Year 57.35% 290.07% 62.08%
3-Year CAGR 9.66% 13.79% 18.22%
5-Year CAGR 21.01% 7.92% 19.82%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.